Company intelligence / Profile preview

ViroStatics

Sassari, Sardinia, Italyvirostatics.com ↗
Ownership
Private
Employees
~10
Development stage
Preclinical
01

Overview

ViroStatics has developed a pipeline of novel host cell kinase inhibitors with unique selectivity profiles for oncology indications such as breast cancer resistant to CDK4/6 inhibitors and mesothelioma. Its lead compound Myrtleciclib demonstrates selective inhibition of CDK9/6/4 with anti-proliferative activity in preclinical models. The company also participates in broad-spectrum antiviral research projects but currently has no active clinical trials registered.

Therapeutic areas
OncologyInfectious Diseases
Modalities
Small molecules (notably kinase inhibitors)Broad-spectrum antivirals
Industry
Biotech
02

Drug pipeline

3 assets

VS411

2

2 more assets in the full pipeline.

03

Partnerships

Collaborates on national/international research projects such as PANVIRIDE under Italy’s National Recovery and Resilience Plan; large international network of partners/collaborators mentioned but not named specifically.

Beyond the preview

Go deeper on ViroStatics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViroStatics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call